Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia-Reference-Cited by-同舟云学术

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia

Published:2023-08-09 Issue:16 Volume:7 Page:4319-4322
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Rankine-Mullings Angela¹,Keenan Russell²,Chakravorty Subarna³^ORCID,Inusa Baba⁴^ORCID,Telfer Paul⁵,Velangi Mark⁶,Ware Russell E.⁷^ORCID,Moss Jon J.⁸,Lloyd Adam L.⁸,Edwards Sarah⁹,Mulla Hussain⁹^ORCID

Affiliation:

1. 1Sickle Cell Unit, Caribbean Institute for Health Research, The University of The West Indies, Mona, Jamaica

2. 2Liverpool Paediatric Haemophilia Centre, Haematology Treatment Centre, Alder Hey Children’s Hospital, NHS Foundation Trust, Liverpool, United Kingdom

3. 3Department of Paediatric Haematology, Kings College Hospital, NHS Foundation Trust, London, United Kingdom

4. 4Department of Paediatric Haematology, Evelina London Children’s Hospital, Guy’s and St. Thomas NHS Foundation Trust, London, United Kingdom

5. 5Department of Paediatric Haematology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom

6. 6Department of Paediatric Haematology, Birmingham Children’s Hospital NHS Foundation Trust, Birmingham, United Kingdom

7. 7Division of Hematology and Global Health Center, Cincinnati Children’s Hospital, Cincinnati, OH

8. 8Bast Inc Limited, Leicester, United Kingdom

9. 9Nova Laboratories Limited, Leicester, United Kingdom

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/16/4319/2072922/blooda_adv-2023-010099-main.pdf

Reference22 articles.

1. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia;Wang;J Pediatr,2001

2. A multicentre, randomised, controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia. (BABY HUG);Wang;Lancet,2011

3. Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia;Ware;Blood,2011

4. Do difficulties in swallowing medication impede the use of hydroxyurea in children?;Bekele;Pediatr Blood Cancer,2014

5. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease;Badawy;Eur J Haematol,2017